Franklin Templeton ETF Trust (HELX)
Perusahaan Manajemen · BATS · Seri S000067393 · Lihat di SEC EDGAR ↗
Data kepemilikan belum tersedia untuk dana ini.
Di halaman ini
- Arus dana Uang yang masuk dan keluar dari dana setiap bulan, dari pengajuan N-PORT.
- Kepemilikan Setiap posisi yang saat ini dipegang oleh dana, dengan bobotnya.
- Pemilik institusional Institusi 13F yang melaporkan kepemilikan ETF ini.
- Dana serupa Dana lain dengan kepemilikan yang tumpang tindih atau ukuran yang sebanding.
Aliran dana (dilaporkan SEC)
- Bulan lalu (Mar 2026)
- +$0
- Kuartal berakhir Mar 2026
- +$1.9M
- 12 bulan terakhir
- +$7.8M
Apr 2025 – Mar 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Komposisi Penuh 61 saham
| Nama | CUSIP | Nilai | % | Saldo | Kategori | Negara |
|---|---|---|---|---|---|---|
| Guardant Health Inc | 40131M109 | $1.5M | 6,77 | 15.718 | EC | US |
| NATERA INC | 632307104 | $1.4M | 6,65 | 7.131 | EC | US |
| Krystal Biotech Inc | 501147102 | $1.1M | 5,32 | 4.418 | EC | US |
| United Therapeutics Corporation | 91307C102 | $996K | 4,64 | 1.680 | EC | US |
| Insmed Inc | 457669307 | $970K | 4,52 | 5.932 | EC | US |
| Bridgebio Pharma Inc | 10806X102 | $905K | 4,22 | 12.192 | EC | US |
| Ligand Pharmaceuticals Incorporated | 53220K504 | $757K | 3,53 | 3.794 | EC | US |
| AstraZeneca PLC | — | $729K | 3,40 | 3.695 | EC | GB |
| Adaptive Biotechnologies Corp | 00650F109 | $670K | 3,12 | 48.245 | EC | US |
| Vertex Pharmaceuticals Incorporated | 92532F100 | $641K | 2,99 | 1.435 | EC | US |
| Samsung Biologics Co Ltd | — | $640K | 2,99 | 652 | EC | KR |
| Medpace Holdings Inc. | 58506Q109 | $637K | 2,97 | 1.327 | EC | US |
| Regeneron Pharmaceuticals, Inc. | 75886F107 | $578K | 2,69 | 748 | EC | US |
| Corteva Inc | 22052L104 | $578K | 2,69 | 6.904 | EC | US |
| Alnylam Pharmaceuticals Inc. | 02043Q107 | $558K | 2,60 | 1.687 | EC | US |
| Eli Lilly & Co. | 532457108 | $545K | 2,54 | 593 | EC | US |
| Ionis Pharmaceuticals, Inc. | 462222100 | $447K | 2,09 | 5.957 | EC | US |
| Tempus AI Inc. | 88023B103 | $395K | 1,84 | 8.726 | EC | US |
| BioNTech SE | 09075V102 | $386K | 1,80 | 4.340 | EC | DE |
| Neurocrine Biosciences Inc | 64125C109 | $355K | 1,65 | 2.693 | EC | US |
| Stoke Therapeutics Inc | 86150R107 | $343K | 1,60 | 10.539 | EC | US |
| Twist Bioscience Corporation | 90184D100 | $341K | 1,59 | 7.184 | EC | US |
| Argenx SE | — | $328K | 1,53 | 459 | EC | NL |
| PTC Therapeutics, Inc. | 69366J200 | $317K | 1,48 | 4.652 | EC | US |
| Travere Therapeutics Inc | 89422G107 | $301K | 1,40 | 10.129 | EC | US |
| Charles River Laboratories International, Inc. | 159864107 | $249K | 1,16 | 1.445 | EC | US |
| CRISPR Therapeutics AG | — | $222K | 1,04 | 4.671 | EC | CH |
| Repligen Corporation | 759916109 | $220K | 1,03 | 1.866 | EC | US |
| Veracyte Inc | 92337F107 | $219K | 1,02 | 6.788 | EC | US |
| Praxis Precision Medicines Inc | 74006W207 | $215K | 1,00 | 667 | EC | US |
| GRAIL Inc | 384747101 | $214K | 1,00 | 4.138 | EC | US |
| Sartorius AG | — | $205K | 0,96 | 841 | EP | DE |
| Danaher Corporation | 235851102 | $199K | 0,93 | 1.050 | EC | US |
| Thermo Fisher Scientific Inc | 883556102 | $192K | 0,90 | 391 | EC | US |
| IQVIA Holdings Inc. | 46266C105 | $171K | 0,80 | 1.005 | EC | US |
| BEAM THERAPEUTICS INC | 07373V105 | $168K | 0,78 | 7.036 | EC | US |
| Jazz Pharmaceuticals PLC | — | $159K | 0,74 | 841 | EC | IE |
| Catalyst Pharmaceuticals Inc. | 14888U101 | $158K | 0,74 | 6.375 | EC | US |
| Cadence Design Systems, Inc. | 127387108 | $151K | 0,71 | 545 | EC | US |
| Agilent Technologies Inc. | 00846U101 | $129K | 0,60 | 1.136 | EC | US |
| Caredx Inc | 14167L103 | $129K | 0,60 | 7.429 | EC | US |
| QIAGEN NV | — | $127K | 0,59 | 3.175 | EC | NL |
| AnaptysBio Inc. | 032724106 | $113K | 0,53 | 2.041 | EC | US |
| SAMSUNG EPIS HOLDINGS CO LTD | — | $113K | 0,53 | 350 | EC | KR |
| Tarsus Pharmaceuticals Inc | 87650L103 | $104K | 0,49 | 1.487 | EC | US |
| Ultragenyx Pharmaceuticals Inc | 90400D108 | $100K | 0,47 | 4.765 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $97K | 0,45 | 4.107 | EC | US |
| Axsome Therapeutics Inc. | 05464T104 | $96K | 0,45 | 566 | EC | US |
| GeneDx Holdings Corp | 81663L200 | $90K | 0,42 | 1.409 | EC | US |
| Rhythm Pharmaceuticals Inc | 76243J105 | $85K | 0,39 | 974 | EC | US |
Halaman 1
dari 2
← Sebelumnya
Berikutnya →
Pemilik institusional (13F) 9 pengaju
Institusi yang melaporkan kepemilikan ETF ini dalam Formulir SEC 13F triwulanan mereka. Hanya posisi long; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Institusi | Nilai | % dari 13F yang dilacak | Saham | Tipe | Per tanggal |
|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.529.544 | 40,42% | 38.272 | Saham | 30 Juni 2026 |
| CITADEL ADVISORS LLC | $1.350.820 | 35,70% | 33.800 | Saham | 30 Juni 2026 |
| LPL Financial LLC | $615.622 | 16,27% | 15.404 | Saham | 30 Juni 2026 |
| OSAIC HOLDINGS, INC. | $125.643 | 3,32% | 3.142 | Saham | 30 Juni 2026 |
| FRANKLIN RESOURCES INC | $106.907 | 2,83% | 2.675 | Saham | 30 Juni 2026 |
| HARBOUR INVESTMENTS, INC. | $50.146 | 1,33% | 1.255 | Saham | 30 Juni 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $5.116 | 0,14% | 128 | Saham | 30 Juni 2026 |
| HUNTINGTON NATIONAL BANK | $14 | 0,00% | 1 | Saham | 30 Juni 2026 |
| JPMORGAN CHASE & CO | $1 | 0,00% | 0 | Saham | 30 Juni 2026 |
Dana sejawat
Serupa berdasarkan ukuran
| Dana | AUM |
|---|---|
| ELIL Direxion Shares ETF Trust | $21.5M |
| HDG ProShares Trust | $21.6M |
| PSCD Invesco Exchange-Traded Fund Tr… | $21.7M |
| UXOC First Trust Exchange-Traded Fun… | $21.8M |
| PQAP PGIM Rock ETF Trust | $21.9M |
| MEXX Direxion Shares ETF Trust | $21.4M |
| DTAN EA Series Trust | $21.4M |
| VEMY Virtus ETF Trust II | $21.3M |
| TMNS T. Rowe Price Exchange-Traded F… | $21.2M |
| CFIT Cambria ETF Trust | $21.2M |